공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 조직 이식 및 장기 이식 시장(2020-2027년) : 시장 예측(제품 종류, 용도, 최종사용자, 지역별), 시장 점유율, 시장 기회 분석

Tissue and Organ Transplantation Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 12월 상품 코드 980026
페이지 정보 영문
가격
US $ 4,500 ₩ 5,220,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,120,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,601,000 PPT Turned PDF (Enterprise User License)


세계의 조직 이식 및 장기 이식 시장(2020-2027년) : 시장 예측(제품 종류, 용도, 최종사용자, 지역별), 시장 점유율, 시장 기회 분석 Tissue and Organ Transplantation Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 조직 이식 및 장기 이식 시장은 이식 시술의 기술적 진보에 의해 예측기간 중 급성장을 나타낼 것으로 예측됩니다.

세계의 조직 이식(Tissue Transplantation) 및 장기 이식(Organ Transplantation) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 법규제 환경, 기술 동향, 시장 규모 추이와 예측, 제품 종류·용도·최종사용자·지역 등 각종 구분별 내역, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

제1장 조사 목적과 전제조건

제2장 시장 개요

제3장 시장 역학, 법규제, 동향 분석

  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
  • 규제 시나리오
  • 영향 분석
  • PEST 분석
  • Porter의 산업 분석
  • 기술 혁신의 진보
  • 시장 동향
  • 이식 투어리즘의 성장
  • 주요 전개

제4장 COVID-19의 영향

제5장 시장 분석과 예측 : 제품 종류

  • 조직 제품
  • 보존 용액
  • 면역 억제제

제6장 시장 분석과 예측 : 용도별

  • 장기 이식
  • 조직 이식

제7장 시장 분석과 예측 : 최종사용자별

  • 병원
  • 이식센터
  • 기타

제8장 시장 분석과 예측 : 지역/주요 국가별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 아프리카
  • 중동

제9장 경쟁 구도

  • 기업 개요
    • CryoLife, Inc.
    • Folio Biosciences
    • Arthrex
    • Abbvie, Inc.
    • Zimmer Biomet
    • Medtronic PLC
    • Novartis AG
    • Stryker Corporation
    • BiolifeSolutions, Inc.
    • Teva Pharmaceuticals
    • Veloxis Pharmaceutical

제10장 섹션

LSH 21.01.14

Title:
Tissue and Organ Transplantation Market, by Product Type (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Application (Organ Transplantation and Tissue Transplantation ), by End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Transplantation is a complex area of medicine because when organs or tissues are transplanted from one person to another, the recipient's immune system can reject and destroy the donor organ or tissue and medication would be needed to suppress this immune response.

Organ transplantation is the surgical operation carried out for replacement of damaged organ of an individual. Donated organs are obtained from living donor, deceased donor or from an animal. Whereas in some cases, an artificial organ is used for the transplantation procedure.

Market Dynamics

The global tissue and organ transplantation market is expected to witness significant growth during the forecast period, owing to the technological advancements in transplantation procedures. For instance, in May 2016, Immucor, Inc., a global leader in transfusion and transplantation diagnostics, launched kidney Solid Organ Response Test, kSORT. It is a molecular gene expression assay that measures a kidney recipient's immune response to predict organ rejection and graft injury.

Key features of the study:

  • This report provides in-depth analysis of the global tissue and organ transplantation market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global tissue and organ transplantation market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include CryoLife, Inc., Folio Biosciences, Arthrex, AbbVie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, Biolife Solutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological up gradation, market expansion, and marketing tactics
  • The global tissue and organ transplantation market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the tissue and organ transplantation market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Tissue and Organ Transplantation Market, By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs

Global Tissue and Organ Transplantation Market, By Application:

  • Organ Transplantation
  • Tissue Transplantation
  • Global Tissue and Organ Transplantation Market, By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Global Tissue and Organ Transplantation Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Company Profiles
  • CryoLife, Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Folio Biosciences
  • Arthrex
  • Abbvie, Inc.
  • Zimmer Biomet
  • Medtronic PLC
  • Novartis AG
  • Stryker Corporation
  • BiolifeSolutions, Inc.
  • Teva Pharmaceuticals
  • Veloxis Pharmaceutical

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Impact Analysis
  • PEST Analysis
  • Porter's Analysis
  • Advancements in Technological Innovations
  • Market Trends
  • Growth in Transplant Tourism
  • Key Developments

4. Global Tissue and Organ Transplantation Market - Impact of Coronavirus (Covid-19) Pandemic

  • Supply side Analysis
  • Demand Side Analysis
  • Impact on Healthcare Industry

5. Global Tissue and Organ Transplantation Market, By Product Type, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Tissue Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Preservation Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Immunosuppressive Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Tissue and Organ Transplantation Market, By Application, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Organ transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Tissue transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Tissue and Organ Transplantation Market, By End User, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Transplant Centers
    • Introduction
    • Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Tissue and Organ Transplantation Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2027
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Company Profiles
    • CryoLife, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Folio Biosciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Arthrex
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abbvie, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zimmer Biomet
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Medtronic PLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Stryker Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BiolifeSolutions, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Teva Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Veloxis Pharmaceutical
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q